Methemoglobin (SpMet^®) is part of Masimo Rainbow SET^®, a noninvasive blood constituent monitoring platform that provides measurements that previously required invasive blood sampling and time-consuming laboratory analysis.

When used with other clinical variables, SpMet may help clinicians assess methemoglobinemia status and help determine treatment and additional test options.

• > Methemoglobinemia is an important clinical condition, more common than generally believed, and is linked to increased morbidity and mortality¹
• > Many procedures and drugs commonly used in clinical practice—including iNO therapy in neonates—have been documented as contributing to induced methemoglobinemia¹
• > Methemoglobinemia occurs across all care areas and patient populations yet is often unrecognized and misdiagnosed¹

"Acquired Methemoglobinemia is fairly common and causes morbidity and mortality in both the inpatient and outpatient settings. Acquired methemoglobinemia is often unrecognized and thus untreated."

- Dr. Rachel Ash-Bernal, et al.

• ¹ Ash-Bernal R, Wise R, Wright SM. Acquired Methemoglobinemia. A Retrospective Series of 138 Cases at 2 Teaching Hospitals. Medicine 2004; 83: 265-272.